Lisa M. Schwartz
- General Decision Sciences top 1%
- Internal Medicine top 1%
- Medical Terminology top 0.5%
- Family Practice top 1%
- General Health Professions top 0.2%
-
- Global Cancer Incidence and Screening 22
- Colorectal Cancer Screening and Detection 16
-
- Health Systems, Economic Evaluations, Quality of Life 21
- Pharmaceutical Economics and Policy 13
-
- Pharmaceutical industry and healthcare 19
-
- BRCA gene mutations in cancer 14
-
- Lung Cancer Diagnosis and Treatment 12
-
- Cardiac Ischemia and Reperfusion 12
- Co-authors
- Steven WoloshinH. Gilbert WelchRenda Soylemez WienerGerd GigerenzerWolfgang GaissmaierElke Kurz‐MilckeBrenda SirovichLeo R. Zacharski
- Journals
- New England Journal of Medicine (5 papers)Proceedings of the National Academy of Sciences (1 paper)The Lancet (2 papers)
- Partner nations
- United StatesGermanyCanada
In The Last Decade
Lisa M. Schwartz
129 papers receiving 9.8k citations
Hit Papers
Peers
Comparison fields: 5 of 189
- General Decision Sciences 319
- Internal Medicine 419
- Medical Terminology 26
- Family Practice 225
- General Health Professions 2.5k
Countries citing papers authored by Lisa M. Schwartz
This map shows the geographic impact of Lisa M. Schwartz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa M. Schwartz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa M. Schwartz more than expected).
Fields of papers citing papers by Lisa M. Schwartz
This network shows the impact of papers produced by Lisa M. Schwartz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa M. Schwartz. The network helps show where Lisa M. Schwartz may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lisa M. Schwartz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 3 | |
| 2 | 2018 | 51 | |
| 3 | 2014 | 25 | |
| 4 | 2014 | 30 | |
| 5 | 2011 | 16 | |
| 6 | 2008 | 11 | |
| 7 | 2007 | 3 | |
| 8 | 2006 | 72 | |
| 9 | 2006 | 81 | |
| 10 | The Public's Enthusiasm for Cancer Screening [3] (multiple letters) | 2004 | 1 |
| 11 | 2004 | 322 | |
| 12 | Enthusiasm for Cancer Screening in the United Statesbreakdown → | 2004 | 507 |
| 13 | 2003 | 281 | |
| 14 | 2003 | 45 | |
| 15 | 2002 | 69 | |
| 16 | 2001 | 53 | |
| 17 | 2000 | 26 | |
| 18 | 2000 | 3 | |
| 19 | 1997 | 262 | |
| 20 | 1993 | 27 |
About Lisa M. Schwartz
Lisa M. Schwartz is a scholar working on Pharmacology, Developmental Neuroscience and Statistics, Probability and Uncertainty, having authored 130 papers that have together received 10.2k indexed citations. Recurring topics across this work include Global Cancer Incidence and Screening (22 papers), Health Systems, Economic Evaluations, Quality of Life (21 papers), Pharmaceutical industry and healthcare (19 papers), Colorectal Cancer Screening and Detection (16 papers), BRCA gene mutations in cancer (14 papers), Pharmaceutical Economics and Policy (13 papers), Lung Cancer Diagnosis and Treatment (12 papers) and Cardiac Ischemia and Reperfusion (12 papers). The work is most often cited by research in General Decision Sciences (319 citations), Internal Medicine (419 citations) and Medical Terminology (26 citations). Lisa M. Schwartz has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include Steven Woloshin, H. Gilbert Welch, Renda Soylemez Wiener, Gerd Gigerenzer, Wolfgang Gaissmaier, Elke Kurz‐Milcke, Brenda Sirovich, Leo R. Zacharski, Deborah L. Ornstein and Cláudia Jacques Lagranha. Their work appears in journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.